CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity.

[1]  M. Juan,et al.  Copy number variation in chemokine superfamily: the complex scene of CCL3L–CCL4L genes in health and disease , 2010, Clinical and experimental immunology.

[2]  K. Yan,et al.  Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris , 2010, The British journal of dermatology.

[3]  Andrew Johnston,et al.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.

[4]  A. Blauvelt,et al.  Circulating Th17, Th22, and Th1 cells are increased in psoriasis. , 2010, The Journal of investigative dermatology.

[5]  Andrew Johnston,et al.  Molecular dissection of psoriasis: integrating genetics and biology. , 2010, The Journal of investigative dermatology.

[6]  Juan Cheng,et al.  Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. , 2010, Clinical immunology.

[7]  X. Estivill,et al.  Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. , 2010, Journal of Investigative Dermatology.

[8]  J. Lupski,et al.  Genomic disorders: A window into human gene and genome evolution , 2010, Proceedings of the National Academy of Sciences.

[9]  A. Enk,et al.  Chemokine receptors in T-cell-mediated diseases of the skin. , 2009, The Journal of investigative dermatology.

[10]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[11]  J. M. Carrascosa,et al.  Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos , 2009 .

[12]  T. Vyse,et al.  Copy number variation in the human genome and its implication in autoimmunity , 2009, Clinical and experimental immunology.

[13]  M. Juan,et al.  Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation , 2009, Genes and Immunity.

[14]  S. Mummidi,et al.  Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children , 2009, AIDS.

[15]  James T. Elder,et al.  Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis , 2009, Nature Genetics.

[16]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[17]  Kenneth G. C. Smith,et al.  Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake , 2008, The Journal of experimental medicine.

[18]  Mark I. McCarthy,et al.  A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs) , 2008, PLoS genetics.

[19]  Lisa C. Zaba,et al.  Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. , 2008, The Journal of investigative dermatology.

[20]  D. Comas,et al.  Population structure in copy number variation and SNPs in the CCL4L chemokine gene , 2008, Genes and Immunity.

[21]  Hong Xin,et al.  The cytokine and chemokine network in psoriasis. , 2007, Clinics in dermatology.

[22]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[23]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[24]  Steven J. Schrodi,et al.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.

[25]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[26]  B. Mulloy,et al.  Cytokines and proteoglycans: an introductory overview. , 2006, Biochemical Society transactions.

[27]  Stefan Jenisch,et al.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.

[28]  M. Juan,et al.  Multiple Products Derived from Two CCL4 Loci: High Incidence of a New Polymorphism in HIV+ Patients1 , 2005, The Journal of Immunology.

[29]  A. Bowcock,et al.  Psoriasis pathophysiology: current concepts of pathogenesis , 2005, Annals of the rheumatic diseases.

[30]  E. von Stebut,et al.  Macrophage inflammatory protein-1. , 2004, The international journal of biochemistry & cell biology.

[31]  W. Modi,et al.  Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. , 2004, Biochemical and biophysical research communications.

[32]  G. Girolomoni,et al.  Chemokine networks in inflammatory skin diseases. , 2004, European journal of dermatology : EJD.

[33]  J. Travers,et al.  Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. , 2003, The Journal of allergy and clinical immunology.

[34]  J. Van Damme,et al.  Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.

[35]  L. Barcellos,et al.  Gene copy number regulates the production of the human chemokine CCL3‐L1 , 2002, European journal of immunology.

[36]  Klaus Ley,et al.  Chemokines and chemokine receptors in leukocyte trafficking. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[37]  J. A. Smandía,et al.  Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. , 2002, Journal of the American Academy of Dermatology.

[38]  J. Bergeron,et al.  The human MIP-1β chemokine is encoded by two paralogous genes, ACT-2 and LAG-1 , 2001, Immunogenetics.

[39]  J. Cyster,et al.  Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.

[40]  T. Ruzicka,et al.  Psoriasis: the plot thickens . . . , 2001, Nature Immunology.

[41]  A. Gottlieb,et al.  Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells , 1995, The Journal of experimental medicine.

[42]  J. Carrascosa,et al.  [Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]. , 2009, Actas dermo-sifiliograficas.

[43]  André Reis,et al.  Psoriasis is associated with increased β-defensin genomic copy number , 2008, Nature Genetics.